Oncology moves fast. so do we.
Fighting Cancer
One Word at a Time
Trusted updates, insights, and resources for clinicians and educators.
Get the Latest
Oncology News
Breaking oncology updates, FDA decisions, and expert perspectives from the Cancer Communicator team.
-
Aspiring doctors may need to find another quarter million dollars to go to school
Workforce access · Federal student loan reform Aspiring doctors may need to find another quarter million dollars to go to school. The federal funding gap created by the…
-
ASCO GU 2026: Perioperative EV/Pembrolizumab Outperforms Gemcitabine/Cisplatin in MIBC
At the 2026 ASCO Genitourinary Cancers Symposium, Matthew D. Galsky, MD, presented results from the phase 3 KEYNOTE-B15 study showing that perioperative enfortumab vedotin plus pembrolizumab improved outcomes…
-
ASCO GI 2026: Encorafenib/Cetuximab Plus FOLFIRI Improves Response in BRAF V600E CRC
At the 2026 Gastrointestinal Cancers Symposium, BREAKWATER Cohort 3 delivered the clearest signal yet that encorafenib plus cetuximab can be paired with FOLFIRI (folinic acid [leucovorin], fluorouracil [5‑FU]…
-
FDA Closes Out 2025 With 16 Oncology Approvals in Six Weeks
The US Food and Drug Administration (FDA) closed out 2025 with 16 hematology/oncology approvals in just six weeks, marking one of the most active periods of the year.…
-
Oral Menin-Based Triplet Shows Strong Early Activity in ND AML
The phase II SAVE trial presented at the 2025 American Society of Hematology (ASH) Annual Meeting (Abstract 47) delivered early but compelling results from an all-oral regimen pairing…
-
FDA Approves Liso-Cel for R/R MZL
On December 4, 2025, the US Food and Drug Administration (FDA) approved the CD19/CD3-directed CAR T-cell therapy lisocabtagene maraleucel (Breyanzi) for adult patients with relapsed or refractory marginal…
Counting Down
ASCO Annual Meeting 2026
May 29 – June 2 · McCormick Place, Chicago
Watch for Cancer Communicator coverage from Chicago.
Don't Miss
Upcoming Conferences
Improving outcomes with the latest evidence.
ESMO Breast Cancer 2026
May 6 - May 8ONS Congress 2026
May 13 - May 17ASCO Annual Meeting 2026
May 29 - June 2EACR 2026 Congress
June 8 - June 11EHA2026 Congress
June 11 - June 14ESMO Targeted Anticancer Therapies Asia Congress 2026
June 12 - June 14
Watch
Featured Series
Video Podcast
Oncology Unscripted with Dr John Marshall
Move over John Oliver and meet Dr John Marshall. Cancer Communicator is proud to partner with Dr Marshall and Decera Clinical Insights to produce this long-running candid program about the changing oncology world. Honest, timely, occasionally hilarious conversations on the people, policy, and science shaping oncology care.
Patient and clinician education
MyCancerHaven
MyCancerHaven was founded by Dr Ravi Vij, a renowned multiple myeloma leader and long-time collaborator. Cancer Communicator partners with MCH to produce educational video series for patients with hematologic malignancies. Check out our most recent series focusing on chronic lymphocytic leukemia.